Pre-operative Redox State Affects 1-Month Survival in Patients With Advanced Heart Failure Undergoing Left Ventricular Assist Device Implantation

Raffaele Caruso, Andrea Garatti, Valentina Sedda, Filippo Milazzo, Jonica Campolo, Tiziano Colombo, Emanuele Catena, Giuliana Cighetti, Claudio Russo, Maria Frigerio, Ettore Vitali, Oberdan Parodi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Left ventricular assist device (LVAD) implantation has proven effective as a bridge to transplantation in end-stage heart failure patients (ESHFPs), although survival during device support is critical. Oxidative stress has been implicated in the development of heart failure, but the influence of redox state on in-hospital post-LVAD outcome has not been clarified. Methods and Results: In this report we describe the oxidant/anti-oxidant profiles of 15 ESHFPs before LVAD placement, 5 of whom did not survive to 1 month, and in 30 subjects without cardiac disease, representing the control group. Conclusions: Preliminary findings suggest that adequate activity of the GPx-1-based anti-oxidant system before device placement is associated with patient survival up to 1 month, despite comparable baseline oxidative stress in patients who both survived and died (within 2 weeks post-LVAD).

Original languageEnglish
Pages (from-to)1177-1181
Number of pages5
JournalJournal of Heart and Lung Transplantation
Volume26
Issue number11
DOIs
Publication statusPublished - Nov 2007

Fingerprint

Heart-Assist Devices
Oxidation-Reduction
Heart Failure
Oxidants
Survival
Oxidative Stress
Equipment and Supplies
Heart Diseases
Transplantation
Control Groups

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Transplantation

Cite this

Pre-operative Redox State Affects 1-Month Survival in Patients With Advanced Heart Failure Undergoing Left Ventricular Assist Device Implantation. / Caruso, Raffaele; Garatti, Andrea; Sedda, Valentina; Milazzo, Filippo; Campolo, Jonica; Colombo, Tiziano; Catena, Emanuele; Cighetti, Giuliana; Russo, Claudio; Frigerio, Maria; Vitali, Ettore; Parodi, Oberdan.

In: Journal of Heart and Lung Transplantation, Vol. 26, No. 11, 11.2007, p. 1177-1181.

Research output: Contribution to journalArticle

Caruso, R, Garatti, A, Sedda, V, Milazzo, F, Campolo, J, Colombo, T, Catena, E, Cighetti, G, Russo, C, Frigerio, M, Vitali, E & Parodi, O 2007, 'Pre-operative Redox State Affects 1-Month Survival in Patients With Advanced Heart Failure Undergoing Left Ventricular Assist Device Implantation', Journal of Heart and Lung Transplantation, vol. 26, no. 11, pp. 1177-1181. https://doi.org/10.1016/j.healun.2007.07.009
Caruso, Raffaele ; Garatti, Andrea ; Sedda, Valentina ; Milazzo, Filippo ; Campolo, Jonica ; Colombo, Tiziano ; Catena, Emanuele ; Cighetti, Giuliana ; Russo, Claudio ; Frigerio, Maria ; Vitali, Ettore ; Parodi, Oberdan. / Pre-operative Redox State Affects 1-Month Survival in Patients With Advanced Heart Failure Undergoing Left Ventricular Assist Device Implantation. In: Journal of Heart and Lung Transplantation. 2007 ; Vol. 26, No. 11. pp. 1177-1181.
@article{80369f0365164f43a30520bc2ecc3631,
title = "Pre-operative Redox State Affects 1-Month Survival in Patients With Advanced Heart Failure Undergoing Left Ventricular Assist Device Implantation",
abstract = "Background: Left ventricular assist device (LVAD) implantation has proven effective as a bridge to transplantation in end-stage heart failure patients (ESHFPs), although survival during device support is critical. Oxidative stress has been implicated in the development of heart failure, but the influence of redox state on in-hospital post-LVAD outcome has not been clarified. Methods and Results: In this report we describe the oxidant/anti-oxidant profiles of 15 ESHFPs before LVAD placement, 5 of whom did not survive to 1 month, and in 30 subjects without cardiac disease, representing the control group. Conclusions: Preliminary findings suggest that adequate activity of the GPx-1-based anti-oxidant system before device placement is associated with patient survival up to 1 month, despite comparable baseline oxidative stress in patients who both survived and died (within 2 weeks post-LVAD).",
author = "Raffaele Caruso and Andrea Garatti and Valentina Sedda and Filippo Milazzo and Jonica Campolo and Tiziano Colombo and Emanuele Catena and Giuliana Cighetti and Claudio Russo and Maria Frigerio and Ettore Vitali and Oberdan Parodi",
year = "2007",
month = "11",
doi = "10.1016/j.healun.2007.07.009",
language = "English",
volume = "26",
pages = "1177--1181",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "11",

}

TY - JOUR

T1 - Pre-operative Redox State Affects 1-Month Survival in Patients With Advanced Heart Failure Undergoing Left Ventricular Assist Device Implantation

AU - Caruso, Raffaele

AU - Garatti, Andrea

AU - Sedda, Valentina

AU - Milazzo, Filippo

AU - Campolo, Jonica

AU - Colombo, Tiziano

AU - Catena, Emanuele

AU - Cighetti, Giuliana

AU - Russo, Claudio

AU - Frigerio, Maria

AU - Vitali, Ettore

AU - Parodi, Oberdan

PY - 2007/11

Y1 - 2007/11

N2 - Background: Left ventricular assist device (LVAD) implantation has proven effective as a bridge to transplantation in end-stage heart failure patients (ESHFPs), although survival during device support is critical. Oxidative stress has been implicated in the development of heart failure, but the influence of redox state on in-hospital post-LVAD outcome has not been clarified. Methods and Results: In this report we describe the oxidant/anti-oxidant profiles of 15 ESHFPs before LVAD placement, 5 of whom did not survive to 1 month, and in 30 subjects without cardiac disease, representing the control group. Conclusions: Preliminary findings suggest that adequate activity of the GPx-1-based anti-oxidant system before device placement is associated with patient survival up to 1 month, despite comparable baseline oxidative stress in patients who both survived and died (within 2 weeks post-LVAD).

AB - Background: Left ventricular assist device (LVAD) implantation has proven effective as a bridge to transplantation in end-stage heart failure patients (ESHFPs), although survival during device support is critical. Oxidative stress has been implicated in the development of heart failure, but the influence of redox state on in-hospital post-LVAD outcome has not been clarified. Methods and Results: In this report we describe the oxidant/anti-oxidant profiles of 15 ESHFPs before LVAD placement, 5 of whom did not survive to 1 month, and in 30 subjects without cardiac disease, representing the control group. Conclusions: Preliminary findings suggest that adequate activity of the GPx-1-based anti-oxidant system before device placement is associated with patient survival up to 1 month, despite comparable baseline oxidative stress in patients who both survived and died (within 2 weeks post-LVAD).

UR - http://www.scopus.com/inward/record.url?scp=36048945988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36048945988&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2007.07.009

DO - 10.1016/j.healun.2007.07.009

M3 - Article

VL - 26

SP - 1177

EP - 1181

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 11

ER -